Aesthetic Plastic Surgery

, Volume 33, Issue 3, pp 409–412

Treatment of Hypertrophic Scars With Intralesional Botulinum Toxin Type A Injections: A Preliminary Report

Original Article

Abstract

Background

Hypertrophic scar is the abnormal appearance of wound healing that usually causes major physical, psychological, and cosmetic problems. Treatment of the hypertrophic scar still is a dilemma due to the lack of effective and excellent methods and agents. Recent reports show that botulinum toxin type A (BTX-A) improves wound healing. Therefore, the authors hypothesized that BTX-A may be favorable for the improvement of hypertrophic scars.

Methods

A total of 19 patients were randomly assigned to a prospective clinical study. At 1-month intervals, BTX-A (2.5 U per cubic centimeter of lesion) was injected in these patients for a total of 3 months. All the patients were followed up for at least half a year. Therapeutic satisfaction was recorded, and the lesions were assessed for erythema, itching sensation, and pliability.

Results

The study was completed by 19 patients. At the half-year follow-up visits, all the patients showed acceptable improvement, and the rate of therapeutic satisfaction was very high. The erythema score, itching sensation score, and pliability score after the BTX-A injection all were significantly lower than before the BTX-A injection. The differences all were statistically significant (P < 0.01).

Conclusion

For the treatment of hypertrophic scars, doctors and patients both found BTX-A acceptable because of its better therapeutic results. Its effect of eliminating or decreasing hypertrophic scars was promising.

Keywords

Botulinum toxin type A Hypertrophic scar Treatment 

References

  1. 1.
    Gassner HG, Sherris DA, Otley CC (2000) Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg 105:1948–1953PubMedCrossRefGoogle Scholar
  2. 2.
    Xiao ZB, Zhang MB (2008) Botulinum toxin type A affects cell cycle distribution of fibroblasts derived from hypertrophic scar. Plast Reconstr Aesth Surg 61:1128–1129.2CrossRefGoogle Scholar
  3. 3.
    David AS, Holger GG (2002) Botulinum Toxin to minimize facial scarring. Facial Plast Surg 18:35–39CrossRefGoogle Scholar
  4. 4.
    Richardson WS, Willis GW, Smith JW (2003) Evaluation of scar formation after botulinum toxin injection or forced balloon dilation to the lower esophageal sphincter. Surg Endosc 17:696–698PubMedCrossRefGoogle Scholar
  5. 5.
    Holger GG, Anthony EB, Clark CO, Derek KB, Andy JB, Amy LW, David AS (2006) Botulinum toxin to improve facial wound healing: a prospective, blinded, placebo-controlled study. Mayo Clin Proc 81:1023–1028CrossRefGoogle Scholar
  6. 6.
    Dhawan S, Chopra S (2007) Nonsurgical approaches for the treatment of anal fissures. Am J Gastroenterol 102:1312–1321PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC and International Society of Aesthetic Plastic Surgery 2009

Authors and Affiliations

  1. 1.Department of Plastic SurgerySecond Affiliated Hospital of Harbin Medical UniversityHarbin CityPeople’s Republic of China
  2. 2.Department of Microbiology, College of Basic Medical ScienceHarbin Medical UniversityHarbin CityPeople’s Republic of China
  3. 3.Department of Plastic SurgeryDaqing Oil HospitalDaqing CityPeople’s Republic of China

Personalised recommendations